Bladder cancer trials in Austria

In Austria 12 Also abroad 626

12 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 11 November 2026. Ask the study team whether a trial fits you.

Phase 1/2Taking people
A Clinical Study of MK-3120 in People With Bladder Cancer (MK-3120-003)
Where
Vienna
Age
18 years and over
People
45 worldwide
Run by
Merck Sharp & Dohme LLC
See details and how to joinNCT07222488 · EU 2025-520467-40-00
Phase 3Taking people
A Study to Evaluate TAR-210 Versus Single Agent Intravesical Cancer Treatment in Participants With Bladder Cancer
Where
Graz, Innsbruck, Leopoldsdorf (Wien), Linz, Salzburg
Age
18 years and over
People
641 worldwide
Run by
Janssen Research & Development, LLC
See details and how to joinNCT06319820
Phase 2/3Taking people
Dato-DXd plus Carboplatin or Cisplatin versus Gemcitabine plus Carboplatin or Cisplatin in Previously Treated la/mUC.
Where
Graz, Innsbruck, Krems An Der Donau, Linz, Salzburg, Vienna
Age
18 years and over
People
343 worldwide
Run by
Daiichi Sankyo Inc.
See details and how to join2024-516906-47-00 · EU 2024-516906-47-00
Phase 1Taking people
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
Where
Graz, Vienna
Age
18 years and over
People
1,394 worldwide
Run by
Exelixis
See details and how to joinNCT05176483 · EU 2023-510061-10-00
Phase 2/3Taking people
Study of Datopotamab Deruxtecan Plus Carboplatin or Cisplatin Versus Gemcitabine Plus Carboplatin or Cisplatin in Participants With Locally Advanced or Metastatic Urothelial Carcinoma
Where
Graz, Krems, Linz, Salzburg, Vienna
Age
18 years and over
People
630 worldwide
Run by
Daiichi Sankyo
See details and how to joinNCT07129993
Phase 2/3Taking people
Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease Progression on or After Immunotherapy
Where
Innsbruck, Vienna
Age
18 years and over
People
470 worldwide
Run by
Bristol-Myers Squibb
See details and how to joinNCT07106762
Phase 1/2Taking people
Clofarabine Therapy in Locally Advanced or Metastatic Urothelial Carcinoma
Where
Vienna
Age
18 years and over
People
50
Run by
Ekaterina Laukhtina
See details and how to joinNCT07034053
Phase 2Taking people
Chemoablation for Low-Grade Bladder Cancer
Where
Vienna
Age
18 years and over
People
47
Run by
Ekaterina Laukhtina
See details and how to joinNCT07019220
Phase 2Taking people
COBRA - Chemoablation for Low Grade Bladder Cancer: A single arm, prospective, open-label, investigator-initiated Phase 2 study
Where
Vienna
Age
18 years and over
People
47
Run by
Medical University Of Vienna
See details and how to join2024-517106-28-00 · EU 2024-517106-28-00
Phase 1/2Taking people
Clofarabine Therapy in Patients with Locally Advanced or Metastatic Urothelial Carcinoma: a Phase 1/2 Dose-Escalation Study
Where
Vienna
Age
18 years and over
People
50
Run by
Medical University Of Vienna
See details and how to join2024-516586-37-00 · EU 2024-516586-37-00
Phase 3Not yet taking people in Austria
Single-Dose Intravesical Chemotherapy After Diagnostic URS
Where
Vienna
Age
18 years and over
People
394
Run by
David D'Andrea
See details and how to joinNCT05810623
No phaseTaking people
Multicentric Prospective T1 Urinary Bladder Cancer Registry
Where
Vienna
Age
18 years to 90 years
People
700
Run by
Medical University of Vienna
See details and how to joinNCT05792033